Skip to main content
Veterinary Medicines

Veyxyl Tabs 800 mg/tbl. na perorálnu aplikáciu pre psy 800 mg/tbl. na intrauterinnú aplikáciu pre kravy, ovce, prasnice a kobyly

Authorised
  • Amoxicillin trihydrate

Product identification

Medicine name:
Veyxyl Tabs 800 mg/tbl. na perorálnu aplikáciu pre psy 800 mg/tbl. na intrauterinnú aplikáciu pre kravy, ovce, prasnice a kobyly
Active substance:
  • Amoxicillin trihydrate
Target species:
  • Dog
  • Cattle (cow)
  • Pig (sow)
  • Sheep (ewe)
  • Horse (mare)
Route of administration:
  • Oral use
  • Intrauterine use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    918.40
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
  • Intrauterine use
    • Cattle (cow)
      • Meat and offal
        4
        day
      • Milk
        1
        day
    • Pig (sow)
      • Meat and offal
        4
        day
    • Sheep (ewe)
      • Meat and offal
        4
        day
      • Milk
        1
        day
    • Horse (mare)
      • Meat and offal
        4
        day
      • Milk
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA03
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/0631/96-S
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."